News & Blog

Tag Archives: biotechnology

The Cancer Moonshot is Ready for Liftoff

On Monday, October 17, 2016, the White House released the final report of theCancer Moonshot Task Force during a special event in Washington, D.C. The report consists of detailed findings and recommendations aimed at accelerating our understanding of cancer and its prevention, early detection, and treatment. As part of this report, the Vice President also unveiled a […]

Moving The Field Toward More Patient-Focused Drug Development

Together with our partners in the Jumpstarting Brain Tumor Drug Development Coalition – Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Education, and the Society for Neuro-Oncology – NBTS has been advocating for the brain tumor research field to take patients’ quality of life into great account during clinical trials. As […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]